REDWOOD CITY, Calif., Feb. 17, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced that Byron Dorgan, former U.S. Senator from North Dakota, has been elected to the company's Board of Directors. Senator Dorgan retired from the Senate in January 2011 after a 30-year career in the U.S. Congress.
"We are very pleased to welcome Byron Dorgan to our Board," said Alan Shaw, Ph.D., President and Chief Executive Officer. "He is a champion of new technologies to enable innovation and has long advocated energy security through a comprehensive national energy policy. As Chairman of the Senate Energy and Water Appropriations Subcommittee, he worked to fund broad development of renewable energy sources. His substantial expertise will be valuable to Codexis."
Senator Dorgan served in the Senate leadership for 16 years, first as Assistant Democratic Floor Leader and then as Chairman of the Democratic Policy Committee. He was Chairman of the Senate Committees and Subcommittees on the issues of Appropriations, Commerce, Energy, Aviation, Water Policy, and Indian Affairs. First elected to Congress in 1980, Dorgan served six terms in the U.S. House of Representatives and three terms in the U.S. Senate. He was also North Dakota's youngest-ever constitutional officer when he was appointed State Tax Commissioner.
While in Congress, he built a reputation as a forward-looking energy policy maker, supporting the use of renewable energy and domestic energy sources, and moving away from a reliance on foreign oil. He also emerged as one of the nation's leading voices on behalf of America's agriculture industry. He worked to expand North Dakota's burgeoning energy sector, preserve a strong safety net for family farmers, and spur economic development.
Senator Dorgan earned his Bachelor of Science degree from the University of North Dakota and his Master of Business Administration from the University of Denver.
Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with Shell and carbon capture with Alstom. Other potential markets for the company's biocatalyst-enabled solutions include chemicals and water treatment. For more information, see www.codexis.com.
|SOURCE Codexis, Inc.|
Copyright©2010 PR Newswire.
All rights reserved